A minimally invasive procedure called genicular artery embolization (GAE) could offer a new treatment for osteoarthritis, potentially reducing the need for knee replacement surgery. This outpatient procedure aims to alleviate chronic knee pain by targeting and reducing blood flow to inflamed areas within the knee joint. Patients have reported significant pain reduction, with some experiencing little to no pain after the treatment.
Genicular artery embolization works by blocking tiny blood vessels associated with inflammation. This process can calm inflammation, thereby reducing swelling and pain. The procedure is considered a middle-ground option for individuals with osteoarthritis who have exhausted conservative treatments but are not yet candidates for major surgery. It is particularly promising for those with mild to moderate knee osteoarthritis.
The procedure typically takes one to two hours and is performed under conscious sedation. A small incision is made to guide a catheter through the femoral artery to the genicular arteries around the knee. Tiny beads are then released into abnormal blood vessels linked to painful, inflamed areas. This reduces blood flow to the targeted vessels.
Recovery from GAE is generally shorter than from knee replacement surgery. Patients are monitored for several hours and usually return home the same day. Early research indicates that the benefits of GAE may last for two to four years in responsive patients. The procedure was first developed in Japan over a decade ago and has gained increasing global attention.
In the United States, the Food and Drug Administration (FDA) has granted "breakthrough device status" to devices used in this area since 2021. This designation aims to accelerate the development and review of medical technologies that offer significant patient advantages. Researchers are conducting clinical trials to understand how GAE affects inflammation and other processes within the knee joint.
Similar approaches are being explored for other painful conditions, including frozen shoulder, tennis elbow, and plantar fasciitis. If ongoing studies continue to demonstrate lasting benefits, GAE could become an important treatment option for millions of people affected by osteoarthritis.
Related stories
Dreaming May Deplete Brain Energy Despite Increased Fuel Supply
New research indicates that dreaming during REM sleep may consume significant brain energy, with neuronal energy levels dropping despite an increase in the brain's fuel supply.
Tirzepatide May Activate Calorie-Burning Brown Fat
A mouse study suggests tirzepatide, sold as Mounjaro and Zepbound, may activate calorie-burning brown fat, offering a new understanding of its metabolic benefits.
ADHD and Autism Diagnoses Show Shifting Demographics in Denmark
A large Danish study found that children diagnosed with ADHD or autism now more closely resemble the general population, suggesting broader identification rather than only an increase in underlying conditions.